MCHX Files 8-K: Q2 2025 Earnings Release and Conference Call Announced

Rhea-AI Filing Summary

Marchex, Inc. announced it is issuing an earnings release and holding a conference call to report results for the quarter ended June 30, 2025. The full earnings release is furnished as Exhibit 99.1 to the Current Report. The company discloses it will present both GAAP and non-GAAP financial measures; the release includes reconciliations and definitions explaining why management believes the non-GAAP measures are useful to investors. The 8-K furnishes this information rather than treating it as formally "filed" under the Exchange Act.

Positive

• Earnings release furnished as Exhibit 99.1, ensuring the full results and commentary will be publicly available
• Non-GAAP measures reconciled to GAAP in the attached release, with definitions and management rationale provided

Negative

• This 8-K text does not include financial results; investors must consult Exhibit 99.1 for numbers and detailed metrics

Insights

Financial Analyst

TL;DR: Routine earnings announcement furnished; non-GAAP reconciliations included, but this filing contains no financial figures itself.

The company used this 8-K to furnish its Q2 2025 earnings release and to announce a conference call. Material financial details are referenced as contained in Exhibit 99.1, and management explicitly uses and reconciles non-GAAP measures. From an analyst perspective, the filing is procedural: it signals when and where results will be available but does not alter the financial record until the exhibit is reviewed.

Investor Relations Specialist

TL;DR: Communication-focused filing that ensures investors can access the earnings release and reconciliation; no new metrics are disclosed here.

This 8-K notifies the market of an upcoming earnings release and conference call and confirms inclusion of non-GAAP reconciliations and definitions in the attached release. For investors and media, the practical takeaway is where to obtain the full results (Exhibit 99.1). The filing itself is informational rather than transformative.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

false000122413300012241332025-08-122025-08-12

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 12, 2025

Marchex, Inc.

(Exact name of Registrant as Specified in its Charter)

Delaware	000-50658	35-2194038
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

1200 5th Ave, Suite 1300, Seattle, Washington		98101
(Address of principal executive offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: (206) 331-3300

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class B Common Stock, par value $0.01 per share		MCHX		The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On August 12, 2025, Marchex, Inc. (“Marchex” or the "Company") is issuing an Earnings Release and holding a conference call regarding its financial results for the second quarter ended June 30, 2025 (the “Earnings Release”). The full text of the Earnings Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 2.02 (including Exhibit 99.1) is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Marchex is referencing non-generally accepted accounting principles ("GAAP") financial information in both the Earnings Release and on the conference call. A reconciliation of these non-GAAP financial measures to the comparable GAAP financial measures is contained in the attached Earnings Release. Disclosures regarding definitions of these financial measures used by Marchex and why Marchex’s management believes these financial measures provide useful information to investors is also included in the Earnings Release.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Earnings Release of Marchex, dated August 12, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, Marchex has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

	MARCHEX, INC.
Date: August 12, 2025	By:	/S/ BRIAN NAGLE
	Name:	Brian Nagle
	Title:	Principal Financial Officer and Principal Accounting Officer

FAQ

What did Marchex (MCHX) file in this 8-K?

The company furnished an earnings release (Exhibit 99.1) and announced a conference call regarding results for the quarter ended June 30, 2025.

Does the 8-K include Marchex's financial figures for Q2 2025?

No. The filing states the full earnings release containing financial figures is furnished as Exhibit 99.1 rather than included inline.

Are non-GAAP measures used and explained by Marchex in this filing?

Yes. The filing states the earnings release and call reference non-GAAP financial information and that reconciliations to GAAP are provided in the release.

Where can investors find the reconciliations and definitions of non-GAAP measures?

Those reconciliations and definitions are included in the earnings release furnished as Exhibit 99.1 to the Current Report.

Who signed the 8-K filing for Marchex?

The filing is signed on behalf of Marchex by Brian Nagle, the company's Principal Financial Officer and Principal Accounting Officer.